Welcome to our dedicated page for BioSig Technologies news (Ticker: BSGM), a resource for investors and traders seeking the latest updates and insights on BioSig Technologies stock.
BioSig Technologies Inc. (NASDAQ: BSGM) provides cutting-edge solutions in cardiac electrophysiology through its flagship PURE EP™ System. This page serves as the definitive source for official company news, including financial results, regulatory milestones, and clinical advancements.
Investors and healthcare professionals will find curated updates on product innovations, partnership announcements, and peer-reviewed research validating BioSig's signal processing technology. Key coverage areas: quarterly earnings reports, FDA clearances, hospital adoption metrics, and intellectual property developments.
All content undergoes strict verification to ensure alignment with SEC disclosure standards and medical device reporting regulations. Bookmark this page for real-time updates on BSGM's progress in enhancing cardiac ablation accuracy through advanced signal visualization technology.
BioSig Technologies (NASDAQ:BSGM) announced a corporate rebranding to Streamex Corp., effective September 12, 2025, following its recent merger with Streamex Exchange Corporation. The company will begin trading under the new ticker symbol "STEX" on the Nasdaq Capital Market exchange.
The rebranding reflects the company's expanded business model and growth strategy. Shareholders are not required to take any action as the CUSIP number remains unchanged, and the corporate structure and operations will continue as before under the new name.
BioSig Technologies (Nasdaq: BSGM) through its Streamex subsidiary has entered into an exclusive partnership with Monetary Metals to create tokenized yield-bearing gold products. The collaboration enables Streamex to leverage Monetary Metals' Gold Yield Marketplace® with up to $1 billion USD in near-term lease capacity.
Through this partnership, Monetary Metals will become Streamex's exclusive gold yield partner, allowing them to develop and distribute digital assets backed by physical gold that generate yield from financing real-world gold businesses, including refineries, mints, and jewelry manufacturers. The partnership combines Streamex's tokenization technology and gold-backed treasury with Monetary Metals' yield platform.
Streamex Exchange Corp (NASDAQ:BSGM) has announced an exclusive long-term strategic partnership with Monetary Metals to launch a pioneering yield-bearing gold product. The partnership grants Streamex exclusive tokenization rights for a minimum of three years, offering investors an estimated 4% annual yield through tokenized bullion assets.
Under the agreement, Streamex will fund at least 10% of eligible Monetary Metals' gold leases and receive revenue share tied to leasing volumes. The collaboration aims to create institutional-grade instruments combining physical bullion with blockchain-based markets, capable of supporting billions in investment.
BioSig Technologies (NASDAQ: BSGM) has provided clarification regarding its merger with Streamex Exchange Corporation and recent Schedule 14A filing. The merger, which closed on May 28, 2025, resulted in 19.99% of BioSig shares being issuable to Streamex shareholders, with remaining issuances pending NASDAQ approval.
The company announced that Proposal No. 1 (Acquisition Proposal) will be adjourned from the September 5, 2025 Special Meeting to a later date, awaiting final NASDAQ approval. This adjournment does not affect the merger closing, company operations, or ongoing financings. The remaining share issuances require formal stockholder approval at the reconvened Special Meeting.
Streamex (NASDAQ:BSGM), a gold tokenization infrastructure company, announced its participation in the upcoming 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th, 2025. The company, which recently merged with BioSig Technologies, will be represented by CEO Henry McPhie and CIO Mitch Williams, who will conduct one-on-one meetings with institutional investors during the conference.
BioSig Technologies (NASDAQ: BSGM), recently merged with Streamex Exchange Corporation, has completed a $15 million public offering of common stock. The company sold 3,852,149 shares at $3.90 per share, with no pre-funded warrants included in the structure.
The offering, managed jointly by Clear Street and Needham & Company, was conducted under an effective S-3 shelf registration. The net proceeds will be primarily used to purchase gold bullion in accordance with the company's investment policy, along with general corporate purposes and working capital needs.
BioSig Technologies (NASDAQ: BSGM) has announced the pricing of its public offering of 3,852,149 shares of common stock at $3.90 per share. The offering, expected to close around August 15, 2025, aims to raise gross proceeds of approximately $15.02 million.
The company plans to use the net proceeds to purchase gold bullion according to its investment policy, along with working capital and general corporate purposes. Clear Street and Needham & Company are serving as joint book-running managers for this offering, which is being conducted under an effective S-3 shelf registration.
BioSig Technologies (NASDAQ: BSGM), following its merger with Streamex Exchange Corporation, has announced plans for an underwritten public offering of common stock and pre-funded warrants. The company intends to use the proceeds to purchase gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company will serve as joint book-running managers for the offering, which will be conducted under an effective S-3 shelf registration. The final size, timing, and terms of the offering remain subject to market conditions.
BioSig Technologies (NASDAQ: BSGM), following its merger with Streamex Exchange Corporation, has engaged Compliance Exchange Group (CXG) to acquire a FINRA and SEC registered broker-dealer. This strategic move positions Streamex to become one of the first Nasdaq-listed companies offering regulated Real-World Asset (RWA) tokenization services.
The acquisition aims to tap into the $22 trillion global gold market within the $142 trillion commodities sector. The company's Solana-based blockchain platform will enable efficient issuance and trading of gold-backed tokens, making gold investment more accessible to both institutional and retail investors. Streamex plans to hold significant vaulted gold quantities by 2026, denominating its balance sheet in physical gold to support a recurring revenue model.
BioSig Technologies (NASDAQ: BSGM) has announced the appointment of Russell Starr as Strategic Advisor to Streamex following their recent merger. Starr, a former Bay Street executive and ex-CEO of DeFi Technologies, brings significant expertise in capital markets and decentralized finance. During his tenure at DeFi Technologies, he led the company to achieve over $200M USD in yearly revenue and grew the share price from $0.07 USD to $4.95 USD.
Starr joins Streamex's distinguished Advisory Board, which includes notable figures such as Frank Giustra (founder of Wheaton Precious Metals), Sean Roosen (founder of Osisko Development Corp), and other industry leaders. The appointment aligns with Streamex's mission to advance tokenized commodities and blockchain infrastructure development.